keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Glucagon-like peptide 1 (1-37), human acetate is a highly potent the GLP-1 receptor agonist.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | Inquiry | $ 397.00 | |
5 mg | Inquiry | $ 894.00 | |
10 mg | Inquiry | $ 1,339.00 | |
25 mg | Inquiry | $ 2,412.00 |
Description | Glucagon-like peptide 1 (1-37), human acetate is a highly potent the GLP-1 receptor agonist. |
In vitro | Glucagon-like peptide 1 (1-37), human acetate is produced by post-translational processing of proglucagon and acts as a regulator of various homeostatic events. GLP-1(1-37) is more stable than GLP-1(7-37), with an initial amount of peptide of 94.7% after exposure to mouse serum for 4 hours[1]. |
In vivo | The administration of Glucagon-like peptide 1 (1-37), human acetate markedly decrease blood glucose levels at 30 min compared with the control group. Glucagon-like peptide 1 (1-37), human acetate decreased glycemic excursion in a dose-dependent manner[1]. |
Molecular Weight | N/A |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Glucagon-like peptide 1 (1-37), human acetate GPCR/G Protein Glucagon Receptor Glucagonlike peptide 1 (137), human acetate Glucagon-like peptide 1 , human Acetate Glucagon like peptide 1 (1 37), human acetate inhibitor inhibit